Viewing Study NCT02841033


Ignite Creation Date: 2025-12-25 @ 3:02 AM
Ignite Modification Date: 2026-03-02 @ 4:22 PM
Study NCT ID: NCT02841033
Status: COMPLETED
Last Update Posted: 2021-05-07
First Post: 2016-06-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Daratumumab for the Treatment of Patients With AL Amyloidosis
Sponsor: Boston Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None AL Amyloidosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Daratumumab View